Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019.


Journal

Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 07 07 2024
accepted: 15 10 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Human respiratory syncytial virus (HRSV) is worldwide one of the leading causes of acute respiratory tract infections in young children and the elderly population. Two distinct subtypes of HRSV (A and B) and a multitude of genotypes have been described. The laboratory of Clinical and Epidemiological Virology (KU Leuven/University Hospitals Leuven) has a long-standing history of HRSV surveillance in Belgium. In this study, the seasonal circulation of HRSV in Belgium was monitored during 8 consecutive seasons prior to the SARS-CoV-2 pandemic (2011-2012 until 2018-2019). By use of a multiplex quantitative real time PCR panel, 27,386 respiratory samples were tested for HRSV. Further subtyping and sequencing of the HRSV positive samples was performed by PCR and Sanger sequencing. The prevalence and positivity rate were estimated in 4 distinct age groups and the circulating strains of each subtype were situated in a global context and in reference to the described genotypes in literature. HRSV circulated in Belgium in a yearly re-occurring pattern during the winter months and both HRSV subtypes co-circulated simultaneously. All HRSV-B strains contained the 60 nt duplication in the HVR2 region of the G gene. Strains of subtype HRSV-A with a 72 nt duplication in the HVR2 region were first observed during the 2011-2012 season and replaced all other circulating strains from 2014 to 2015 onwards.

Sections du résumé

BACKGROUND BACKGROUND
Human respiratory syncytial virus (HRSV) is worldwide one of the leading causes of acute respiratory tract infections in young children and the elderly population. Two distinct subtypes of HRSV (A and B) and a multitude of genotypes have been described. The laboratory of Clinical and Epidemiological Virology (KU Leuven/University Hospitals Leuven) has a long-standing history of HRSV surveillance in Belgium.
METHODS METHODS
In this study, the seasonal circulation of HRSV in Belgium was monitored during 8 consecutive seasons prior to the SARS-CoV-2 pandemic (2011-2012 until 2018-2019). By use of a multiplex quantitative real time PCR panel, 27,386 respiratory samples were tested for HRSV. Further subtyping and sequencing of the HRSV positive samples was performed by PCR and Sanger sequencing. The prevalence and positivity rate were estimated in 4 distinct age groups and the circulating strains of each subtype were situated in a global context and in reference to the described genotypes in literature.
RESULTS RESULTS
HRSV circulated in Belgium in a yearly re-occurring pattern during the winter months and both HRSV subtypes co-circulated simultaneously. All HRSV-B strains contained the 60 nt duplication in the HVR2 region of the G gene. Strains of subtype HRSV-A with a 72 nt duplication in the HVR2 region were first observed during the 2011-2012 season and replaced all other circulating strains from 2014 to 2015 onwards.

Identifiants

pubmed: 39468663
doi: 10.1186/s12985-024-02542-4
pii: 10.1186/s12985-024-02542-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

270

Informations de copyright

© 2024. The Author(s).

Références

Shi T, McAllister DA, O’Brien KL, Simões EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390:946–58.
pubmed: 28689664 pmcid: 5592248 doi: 10.1016/S0140-6736(17)30938-8
Du Y, Yan R, Wu X, Zhang X, Chen C, Jiang D, et al. Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019: a systematic analysis of the global burden of disease 2019 study. Int J Infect Dis. 2023;1(135):70–6.
doi: 10.1016/j.ijid.2023.08.008
Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–544.
doi: 10.1016/S0140-6736(16)31012-1
Ramaekers K, Keyaerts E, Rector A, Borremans A, Beuselinck K, Lagrou K, et al. Prevalence and seasonality of six respiratory viruses during five consecutive epidemic seasons in Belgium. J Clin Virol. 2017;94:72–8.
pubmed: 28772168 doi: 10.1016/j.jcv.2017.07.011
Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019;7(8):e1031–45.
pubmed: 31303294 doi: 10.1016/S2214-109X(19)30264-5
Baker RE, Mahmud AS, Wagner CE, Yang W, Pitzer VE, Viboud C, et al. Epidemic dynamics of respiratory syncytial virus in current and future climates. Nat Commun. 2019;10:5512.
pubmed: 31797866 pmcid: 6892805 doi: 10.1038/s41467-019-13562-y
Rima B, Collins P, Easton A, Fouchier R, Kurath G, Lamb R, et al. ICTV virus taxonomy profile: pneumoviridae. J Gen Virol. 2017;98(December):2912–3.
pubmed: 29087278 pmcid: 5775899 doi: 10.1099/jgv.0.000959
Ramaekers K, Rector A, Cuypers L, Lemey P, Keyaerts E, Van Ranst M. Towards a unified classification for human respiratory syncytial virus genotypes. Virus Evol. 2020;6(2):1–11.
doi: 10.1093/ve/veaa052
Salimi V, Viegas M, Trento A, Agoti CN, Anderson LJ, Avadhanula V, et al. Proposal for human respiratory syncytial virus nomenclature below the species level. Emerg Infect Dis. 2021;27(6):1–9.
pubmed: 34013862 doi: 10.3201/eid2706.204608
Goya S, Ruis C, Neher RA, Meijer A, Aziz A, Hinrichs AS, et al. The unified proposal for classification of human respiratory syncytial virus below the subgroup level. medRxiv. 2024; February.
Battles MB, McLellan JS. Respiratory syncytial virus entry and how to block it. Nat Rev Microbiol. 2019;17(4):233–45.
pubmed: 30723301 pmcid: 7096974 doi: 10.1038/s41579-019-0149-x
Tan L, Lemey P, Houspie L, Viveen MC, Jansen NJG, van Loon AM, et al. Genetic variability among complete human respiratory syncytial virus subgroup a genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS ONE. 2012;7(12):e51439.
pubmed: 23236501 pmcid: 3517519 doi: 10.1371/journal.pone.0051439
Trento A, Viegas M, Galiano M, Videla C, Carballal G, Mistchenko AS, et al. Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol. 2006;80(2):975–84.
pubmed: 16378999 pmcid: 1346866 doi: 10.1128/JVI.80.2.975-984.2006
Eshaghi A, Duvvuri VR, Lai R, Nadarajah JT, Li A, Patel SN, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide g gene duplication. PLoS ONE. 2012;7(3):e32807.
pubmed: 22470426 pmcid: 3314658 doi: 10.1371/journal.pone.0032807
Pangesti KNA, Abd El Ghany M, Walsh MG, Kesson AM, Hill-Cawthorne GA. Molecular epidemiology of respiratory syncytial virus. Rev Med Virol. 2018;28(2):1–11.
doi: 10.1002/rmv.1968
McLellan JS, Ray WC, Peeples ME. Structure and function of RSV surface glycoproteins. Curr Top Microbiol Immunol. 2013;372:83–104.
pubmed: 24362685 pmcid: 4211642
Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011;162:80–99.
pubmed: 21963675 doi: 10.1016/j.virusres.2011.09.020
Zlateva KT, Lemey P, Vandamme AM, Van Ranst M. Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment G glycoprotein. J Virol. 2004;78(9):4675–83.
pubmed: 15078950 pmcid: 387670 doi: 10.1128/JVI.78.9.4675-4683.2004
Zlateva KT, Lemey P, Moës E, Vandamme AM, Van Ranst M. Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol. 2005;79(14):9157–67.
pubmed: 15994810 pmcid: 1168771 doi: 10.1128/JVI.79.14.9157-9167.2005
Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol. 2007;45(9):3022–30.
pubmed: 17609323 pmcid: 2045289 doi: 10.1128/JCM.00339-07
Houspie L, Lemey P, Keyaerts E, Reijmen E, Vergote V, Vankeerberghen A, et al. Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes. PLoS ONE. 2013;8(4):e60416.
pubmed: 23577109 pmcid: 3618235 doi: 10.1371/journal.pone.0060416
Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016.
doi: 10.1007/978-3-319-24277-4
RStudio Team. RStudio: Integrated Development for R. 2020.
Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–80.
pubmed: 23329690 pmcid: 3603318 doi: 10.1093/molbev/mst010
Larsson A. AliView: a fast and lightweight alignment viewer and editor for large datasets. Bioinformatics. 2014;30(22):3276–8.
pubmed: 25095880 pmcid: 4221126 doi: 10.1093/bioinformatics/btu531
Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and high-performance computing Europe PMC funders group. Nat Methods. 2012;9(8):772.
pubmed: 22847109 pmcid: 4594756 doi: 10.1038/nmeth.2109
Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30(9):1312–3.
pubmed: 24451623 pmcid: 3998144 doi: 10.1093/bioinformatics/btu033
Revell LJ. phytools: an R package for phylogenetic comparative biology (and other things). Methods Ecol Evol. 2012;3(2):217–23.
doi: 10.1111/j.2041-210X.2011.00169.x
Paradis E, Schliep K. Phylogenetics ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019;35(3):526–8.
pubmed: 30016406 doi: 10.1093/bioinformatics/bty633
Yu G, Smith DK, Zhu H, Guan Y, Lam TTY. Ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol. 2017;8(1):28–36.
doi: 10.1111/2041-210X.12628
Yu G, Tsan T, Lam Y, Zhu H, Guan Y. Two methods for mapping and visualizing associated data on phylogeny using Ggtree. Mol Biol Evol. 2018;35(12):3041–3.
pubmed: 30351396 pmcid: 6278858 doi: 10.1093/molbev/msy194
Baek HY, Choi EH, Song MS, Pascua PNQ, Kwon HI, Park SJ, et al. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol. 2012;157:1039–50.
pubmed: 22402914 doi: 10.1007/s00705-012-1267-1
Cattoir L, Vankeerberghen A, Boel A, Van Vaerenbergh K, De Beenhouwer H. Epidemiology of RSV and hMPV in Belgium: a 10-year follow-up. Acta Clin Belgica: Int J Clin Lab Med. 2019;74(4):229–35.
doi: 10.1080/17843286.2018.1492509
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–59.
pubmed: 15858184 doi: 10.1056/NEJMoa043951
Ma X, Conrad T, Alchikh M, Reiche J, Schweiger B, Rath B. Can we distinguish respiratory viral infections based on clinical features? A prospective pediatric cohort compared to systematic literature review. Rev Med Virol. 2018;28:e1997.
pubmed: 30043515 pmcid: 7169127 doi: 10.1002/rmv.1997
Kestler M, Muñoz P, Mateos M, Adrados D, Bouza E. Respiratory syncytial virus burden among adults during flu season: an underestimated pathology. J Hosp Infect. 2018;100(4):463–8.
pubmed: 29614245 doi: 10.1016/j.jhin.2018.03.034
Nagayama Y, Tsubaki T, Nakayama S, Sawada K, Taguchi K, Tateno N, et al. Gender analysis in acute bronchiolitis due to respiratory syncytial virus. Pediatr Allergy Immunol. 2006;17(1):29–36.
pubmed: 16426252 doi: 10.1111/j.1399-3038.2005.00339.x
Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis. 2014;209(Suppl 3):S120–6.
pubmed: 24966192 pmcid: 4072001 doi: 10.1093/infdis/jiu232
Duvvuri VR, Granados A, Rosenfeld P, Bahl J, Eshaghi A, Gubbay JB. Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics. Sci Rep. 2015;30(5):14268.
doi: 10.1038/srep14268
Sáez-López E, Cristóvão P, Costa I, Pechirra P, Conde P, Guiomar R. Epidemiology and genetic variability of respiratory syncytial virus in Portugal, 2014–2018. J Clin Virol. 2019;121(September):104200.
pubmed: 31707201 pmcid: 7106440 doi: 10.1016/j.jcv.2019.104200
Al-Sharif HA, El-Kafrawy SA, Yousef JM, Kumosani TA, Kamal MA, Khathlan NA, et al. Dominance of the ON1 genotype of RSV-A and BA9 genotype of RSV-B in respiratory cases from Jeddah, Saudi Arabia. Genes (Basel). 2020;11(11):1–19.
doi: 10.3390/genes11111323
Kamau E, Otieno JR, Lewa CS, Mwema A, Murunga N, Nokes DJ, et al. Evolution of respiratory syncytial virus genotype BA in Kilifi, Kenya, 15 years on. Sci Rep. 2020;10(1):1–12.
doi: 10.1038/s41598-020-78234-0
Luo HJ, Huang XB, Zhong HL, Ye CX, Tan X, Zhou K, Yuan L, Zhang SF, Zhu X, Lin CJ, Wang WJ. Epidemiological characteristics and phylogenic analysis of human respiratory syncytial virus in patients with respiratory infections during 2011–2016 in southern China. Int J Infect Dis. 2020;1(90):5–17.
doi: 10.1016/j.ijid.2019.10.009
Hotard AL, Lee S, Currier MG, Crowe JE, Sakamoto K, Newcomb DC, et al. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J Virol. 2015;89(1):512–22.
pubmed: 25339762 doi: 10.1128/JVI.02472-14
Otieno JR, Kamau EM, Oketch JW, Ngoi JM, Gichuki AM, Binter S, et al. Whole genome analysis of local Kenyan and global sequences unravels the epidemiological and molecular evolutionary dynamics of RSV genotype ON1 strains. Virus Evol. 2018;4(2):27.
doi: 10.1093/ve/vey027
Agoti CN, Otieno JR, Gitahi CW, Cane PA, Nokes DJ. Rapid spread and diversification of respiratory syncytial virus genotype ON1, Kenya. Emerg Infect Dis. 2014;20(6):950–9.
pubmed: 24856417 pmcid: 4036793 doi: 10.3201/eid2006.131438
Katzov-Eckert H, Botosso VF, Neto EA, de Zanotto PMA, Tavano Peret EA, Ueda M, et al. Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children. PLoS ONE. 2012;7(10):e41953.
pubmed: 23077477 pmcid: 3471929 doi: 10.1371/journal.pone.0041953
Goya S, Galiano M, Nauwelaers I, Trento A, Openshaw PJ, Mistchenko AS, et al. Toward unified molecular surveillance of RSV: a proposal for genotype definition. Influenza Other Respir Viruses. 2020; (May 2019):irv.12715.
Peret TCT, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol. 1998;79:2221–9.
pubmed: 9747732 doi: 10.1099/0022-1317-79-9-2221
Shobugawa Y, Saito R, Sano Y, Zaraket H, Suzuki Y, Kumaki A, et al. Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan. J Clin Microbiol. 2009;47(8):2475–82.
pubmed: 19553576 pmcid: 2725673 doi: 10.1128/JCM.00115-09
Cui G, Zhu R, Qian Y, Deng J, Zhao L, Sun Y, et al. Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups A and B in children in recent five consecutive years. PLoS ONE. 2013;8(9):e75020.
pubmed: 24069376 pmcid: 3775769 doi: 10.1371/journal.pone.0075020
Dapat IC, Shobugawa Y, Sano Y, Saito R, Sasaki A, Suzuki Y, et al. New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin Microbiol. 2010;48(9):3423–7.
pubmed: 20610675 pmcid: 2937669 doi: 10.1128/JCM.00646-10
Gimferrer L, Andrés C, Campins M, Codina MG, Rodrigo JA, Melendo S, et al. Circulation of a novel human respiratory syncytial virus Group B genotype during the 2014–2015 season in Catalonia (Spain). Clin Microbiol Infect. 2016;22:97.e5-97.e8.
pubmed: 26408279 doi: 10.1016/j.cmi.2015.09.013
Di Giallonardo F, Kok J, Fernandez M, Carter I, Geoghegan JL, Dwyer DE, et al. Evolution of human respiratory syncytial virus (RSV) over multiple seasons in New South Wales, Australia. Viruses. 2018;10(476):1–13.
Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023;23(1):e2-21.
pubmed: 35952703 doi: 10.1016/S1473-3099(22)00291-2
Bossuyt N, Vermeulen M, Denayer S, Barbezange C, De Schreye R, Moreels S, et al. Bulletin acute luchtweginfecties. 2023.

Auteurs

Kaat Ramaekers (K)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1040, 3000, Leuven, Belgium. kaat.ramaekers@gmail.com.

Els Keyaerts (E)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1040, 3000, Leuven, Belgium.
Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Lieselot Houspie (L)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1040, 3000, Leuven, Belgium.
QbD Clinical, Groeneborgerlaan 16, 2810, Wilrijk, Belgium.

Kurt Beuselinck (K)

Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Marijke Reynders (M)

Unit of Molecular Microbiology, Medical Microbiology, Department of Laboratory Medicine, Algemeen Ziekenhuis Sint-Jan, 3000, Brugge, Belgium.

Katrien Lagrou (K)

Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Marc Van Ranst (M)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1040, 3000, Leuven, Belgium.
Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Annabel Rector (A)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1040, 3000, Leuven, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH